Carfilzomib (Kyprolis)

Carfilzomib, also known by the brand name Kyprolis, is an intravenous prescription medication used to treat multiple myeloma, a type of blood cancer. It works as a proteasome inhibitor, meaning it blocks certain enzyme complexes inside cancer cells so the cells cannot survive. This topic covers practical details about what to expect during your infusion visits, along with ways to manage common side effects like fatigue, nausea, or changes in blood pressure. You can also connect with other patients and caregivers to share experiences and find reliable information to support you throughout your treatment plan.